Fat cells fight fistula failure: early trial tests Patient's own stem cells
NCT ID NCT02808208
Summary
This early-stage study is testing whether stem cells taken from a patient's own body fat can help keep their dialysis access point from failing. The cells are applied during the surgery to create the access point. The goal is to see if this approach is safe and can improve how well the access point works for people with kidney failure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.